期刊文献+

小檗胺逆转MCF7/ADR细胞耐药性及其机制探讨 被引量:4

THE STUDY OF REVERSAL RESISTANCE EFFECT AND ITS MECHANISM OF BERBAMINE IN MCF7/ADR CELLS
原文传递
导出
摘要 目的 探讨钙调素拮抗剂小檗胺 (BBM)逆转多药耐药的可能性及其机制。 方法 乳腺癌细胞MCF7及其耐阿霉素 (ADR)MCF7 ADR细胞与ADR及不同浓度BBM共培养 ,经四唑盐 (MTT)比色法计算半数抑制浓度 (IC50 )、耐药倍数和增敏倍数 ;流式细胞仪检测细胞内ADR相对含量和P糖蛋白 (P gp)表达水平 ;半定量RT PCR检测mdr1基因mRNA表达。 结果 ADR对MCF7和MCF7 ADR的IC50 分别为 (0 98± 0 0 6 ) μmol L和 (10 1 2 0±5 72 ) μmol L ;MCF7 ADR对ADR的耐药倍数为 10 3。MCF7 ADR细胞 5 μmol L、10 μmol L和 2 0 μmol LBBM时对ADR呈剂量依赖性增敏作用 ,增敏倍数分别为 2 76、5 88和 2 8 2 6倍 (均P值 <0 0 1)。用 10 μmol 或 2 0 μmol LBBM处理MCF7 ADR细胞 2h ,细胞内的ADR相对含量增加 2 4 9和 2 81倍 (P <0 0 1) ;处理 72h使P gp表达分别下降10 0 9%和 6 2 82 % (均P值 <0 0 1) ,且mdr1基因mRNA相对表达值也呈下调趋势。 结论 BBM提高耐药细胞MCF7 ADR胞内的ADR浓度 ,下调mdr1基因及P gp的表达 ,使其对ADR的敏感性显著增高。 Objective To explore the efficacy of calmodulin antagonist berbamine(BBM)on multidrug resistance(MDR)reversal and its mechanism. Methods Human breast cancer cell line MCF7 and its adriamycin-resistant counterpart MCF7/ADR were used in the study.The cells were cultured with ADR and different concentration of BBM. MTT assay was used to analyze the effect of BBM on cell growth inhibition.According to the MTT assay,the 50% inhibitory concentration(IC 50 ),the multiples of drug resistance and increased sensitivity of ADR were calculated.The concentration of intracellular ADR and expression level of P-glycoprotein(P-gp)were detected by flowcytometry(FCM).The mRNA expression level of mdr1 gene was detected by semi-quantitative reverse transcriptase polymerase chain reaction(RT-PCR)with β-actin as internal reference. Results The IC 50 of ADR in MCF7 and MCF7/ADR cells were(0.98±0.06)μmol/L and(101.20±5.72)μmol/L,respectively.The resistant multiple of MCF/ADR cells to ADR was 103 folds higher than that of MCF7 cells.BBM increased the chemo-sensitivity of ADR in MCF7/ADR cells with dose-dependent relationship,i.e.when 5*!μmol/L ,10*!μmol/L and 20*!μmol/L BBM was added into the culture the chemo-sensitivity of ADR was increased to 2.76,5.88,and 28.26 folds(P<0.01),respectively.After treating MCF7/ADR cells by 10*!μmol/L or 20*!μmol/L BBM for 2 hours the accumulation of intracellular ADR was increased to 2.49 and 2.81 folds(P<0.01),while treating for 72 hours the expression of P-gp was decreased 10.09% and 62.82%(P<0.01),respectively,with down-regulated mRNA expression of mdr1 gene.Conclusion BBM could increase intracellular concentration of ADR in MCF7/ADR,down-regulate expre-ssion level of both mdr1 mRNA and P-gp so that the sensitivity of MCF7/ADR to ADR was increased significantly.
出处 《解剖学报》 CAS CSCD 北大核心 2004年第2期161-164,共4页 Acta Anatomica Sinica
基金 美国中华医学基金会 (CMB)资助项目
关键词 小檗胺 逆转 MCF7/ADR细胞 耐药性 P糖蛋白 MDRL基因 乳腺癌 肿瘤 化疗 Berbamine Adriamycin MCF7/ADR cell line P-gp mdr1 gene
  • 相关文献

参考文献10

  • 1Liu JW,Qi SL,Zhu HF,et al.The effect of calmodulin antagonist berbamine derivative-EBB on hepatoma in vitro and vivo [J].Chin Med J,2002,115(5):759-762.
  • 2Marks DC,Belov L,Davey MW,et al.The MTT cell viability assay for cytotoxicity testing in multidrug-resistance human leukemic cells [J]. Leukemia Res,1992,16(12):1165-1173.
  • 3Michieli M, Damiani D,Ermacora A,et al.P-glycoprotein,lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukemias:biological and clinical implications [J].Br J Haematol,1999,104(2):328-335.
  • 4Lopes EC,Scolnik M,Alvarez E,et al.Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells [J]. Leukemia Res,2001,25(1):85-93.
  • 5Benderra Z,Trussardi A, Morjani H, et al.Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein [J].Eur J Cancer.2000,36(3):428-434.
  • 6Massart C,Gibassier J,Lucas C,et al.Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by cylosporin A and verapamil [J].Bull Cancer,1996,83(1):39-45.
  • 7Stein U,Walther W,Shoemaker RH.Modulation of mdr1 expression by cytokines in human colon carcinoma cell:an approach for reversal of multidrug resistance [J].Br J Cancer,1996,74(9):1384-1391.
  • 8Motomura S,Motoj T,Takanashi M,et al.Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemia blast cells by multidrug resistance gene (mdr1)antisense oligonucleotides [J].Blood,1998,91(9):3163-3171.
  • 9Raderer M, Scheithauer W.Clinical trials of agents that reverse multidrug resistance [J].Cancer,1993,72(12):3553-3563.
  • 10赵艳玲,李柏岩,乔国芬,周虹,李文汉.小檗胺对ROCC介导的血管平滑肌细胞内游离钙的影响[J].中国药理学通报,2000,16(4):450-452. 被引量:14

二级参考文献8

  • 1Qiao G F,药学学报,1999年,20卷,4期,292页
  • 2Cui J,Cell Res,1995年,5卷,165页
  • 3Xu J L,中国药理学通报,1994年,10卷,104页
  • 4Li B Y,药学学报,1992年,9卷,412页
  • 5Li B Y,中国药理学报,1991年,12卷,1期,48页
  • 6Wu X C,Asia Pac J Pharmacol,1990年,5卷,191页
  • 7Li G Z,Asia Pac J Pharmacol,1989年,4卷,1页
  • 8Zhou Z D,药学学报,1980年,15卷,248页

共引文献13

同被引文献100

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部